August 27, 2020
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests. The study, published in the Proceedings of the National Academy of Sciences, suggests that splitting immunotoxins into two inactive and […]